Drug Topics January 22, 2026
With unprecedented changes to Medicare Part D plans at the top of the year, experts from ASCP help pharmacy businesses understand key provisions under the IRA.
Throughout the 21st century, health policy and legislation impacting American patients has been a controversial topic of discussion both within health care arenas and outside of them. With the Affordable Care Act (ACA) being one of those debated-upon statutes, the Inflation Reduction Act (IRA) of 2022 later built on the ACA, extending into 2026 and beyond, among other provisions.1
Today, the IRA’s provisions are impacting pharmacy businesses and making their potential for financial sustainability a significant challenge. Now, with new and required Medicare drug pricing for the pharmacies that dispense Part D drugs—known as...
Today's Sponsors
Today's Sponsor